Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Gaynon

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|August 26, 1998
Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID miceF M Uckun, B J Waurzyniak, M G Sensel, et al.
Cancer|April 7, 1998
Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group ExperienceP S Gaynon, R P Qu, R J Chappell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemiaF M Uckun, L Stork, N Seibel, et al.
Leukemia|February 24, 2001
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995P S Gaynon, M E Trigg, N A Heerema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer GroupJ Nachman, H N Sather, J M Cherlow, et al.
Medical and Pediatric Oncology|January 1, 1991
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting featuresP S Gaynon, P G Steinherz, W A Bleyer, et al.
Medical and Pediatric Oncology|January 1, 1990
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting featuresP S Gaynon, W A Bleyer, P G Steinherz, et al.
Cancer|May 15, 1993
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatmentJ Nachman, H N Sather, J D Buckley, et al.
Leukemia|December 18, 2009
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group ReportP S Gaynon, A L Angiolillo, W L Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemiaH S Maurer, P G Steinherz, P S Gaynon, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|August 26, 1998
Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID miceF M Uckun, B J Waurzyniak, M G Sensel, et al.
Cancer|April 7, 1998
Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group ExperienceP S Gaynon, R P Qu, R J Chappell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemiaF M Uckun, L Stork, N Seibel, et al.
Leukemia|February 24, 2001
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995P S Gaynon, M E Trigg, N A Heerema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer GroupJ Nachman, H N Sather, J M Cherlow, et al.
Medical and Pediatric Oncology|January 1, 1991
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting featuresP S Gaynon, P G Steinherz, W A Bleyer, et al.
Medical and Pediatric Oncology|January 1, 1990
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting featuresP S Gaynon, W A Bleyer, P G Steinherz, et al.
Cancer|May 15, 1993
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatmentJ Nachman, H N Sather, J D Buckley, et al.
Leukemia|December 18, 2009
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group ReportP S Gaynon, A L Angiolillo, W L Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemiaH S Maurer, P G Steinherz, P S Gaynon, et al.
Pageof 7